AU2003239442A1 - Agents which interact with a serotonin transporter for the treatment of cancer - Google Patents

Agents which interact with a serotonin transporter for the treatment of cancer

Info

Publication number
AU2003239442A1
AU2003239442A1 AU2003239442A AU2003239442A AU2003239442A1 AU 2003239442 A1 AU2003239442 A1 AU 2003239442A1 AU 2003239442 A AU2003239442 A AU 2003239442A AU 2003239442 A AU2003239442 A AU 2003239442A AU 2003239442 A1 AU2003239442 A1 AU 2003239442A1
Authority
AU
Australia
Prior art keywords
cancer
interact
agents
treatment
serotonin transporter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003239442A
Inventor
Nicholas Mark Barnes
John Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Birmingham
Original Assignee
University of Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Birmingham filed Critical University of Birmingham
Publication of AU2003239442A1 publication Critical patent/AU2003239442A1/en
Abandoned legal-status Critical Current

Links

AU2003239442A 2002-02-01 2003-02-03 Agents which interact with a serotonin transporter for the treatment of cancer Abandoned AU2003239442A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0202337.2 2002-02-01

Publications (1)

Publication Number Publication Date
AU2003239442A1 true AU2003239442A1 (en) 2003-09-02

Family

ID=

Similar Documents

Publication Publication Date Title
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
AU2003224654A1 (en) Photodynamic therapy for pre-melanomas
AU2002361879A1 (en) Dependence-chain processors
AU2003261987A1 (en) Spotlight
AUPS054702A0 (en) Cancer therapy
AU2003224076A1 (en) Antibody combination useful for tumor therapy
AU2003217275A1 (en) Azabicyclic compounds for the treatment of disease
AU2003256655A1 (en) Therapeutic compounds for treating dyslipidemic conditions
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2003224002A1 (en) Drugs for the arthritis treatment
AU2002317775A1 (en) Dual cure emulsions
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2003251904A1 (en) Combinations of drugs for the treatment of neoplasms
AU2003251875A1 (en) Combination therapy for the treatment of neoplasms
AU2003223538A1 (en) Methods for the treatment of cancer
AU2003215150A1 (en) Therapeutic compounds
AU2003222449A1 (en) Medicine for treating cancer
AU2002952355A0 (en) Cephem compounds
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
AU2002335304A1 (en) The use of berberine as insulin sensitizer
AU2003296242A1 (en) Thia-epothilone derivatives for the treatment of cancer
AU2003239442A1 (en) Agents which interact with a serotonin transporter for the treatment of cancer
AU2003246655A1 (en) Confocal 3d-scanning absorption
AU2003302705A1 (en) Germ-responsive promoter
AU2003244633A1 (en) Methods for the treatment of sinusitis